The St. Jude Global Pathology and Laboratory Medicine Transversal aims to improve diagnostic testing worldwide.
The St. Jude Vector Laboratory advances gene therapy through viral vectors, advancing scientific and therapeutic innovation.
A new rapid budgeting tool increases the likelihood pediatric cancer will be included in national cancer control plans globally.
A CRISPR screen reveals a potential combination therapy for relapsed neuroblastoma.
St. Jude Global helps provide a framework for rebuilding health care capacity after a crisis.
Explore how tumor-associated macrophages shape CAR T-cell therapy efficacy in high-grade gliomas.
Discover how disruption ribosomes creation provides promise for “undruggable” cancers.